Highlights 2012 - Gilde Healthcare

Highlights 2012

December 20, 2012

Season’s Greetings and best wishes for a healthy and prosperous New Year in 2013 from Gilde Healthcare Partners.

We look back on an eventful year of successes and a lot of hard work. Click below for our 2012 highlights.

Gilde wishes you a prosperous and healthy 2013

Gilde Healthcare company Big Health receives US FDA Clearance for DaylightRx

First FDA cleared non-drug treatment for generalized anxiety disorder. Clearance is the second FDA-clearance for Big Health. Big Health, a leading developer of digital mental health treatments, has been granted clearance by the U.S. Food...
September 5, 2024

Gilde Healthcare company Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer

The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein degraders into the clinic and building a robust pipeline Appointment follows achievement of three key milestones for Amphista...
September 3, 2024

Gilde Healthcare appoints Jan Willem Bakker as Head of Investor Relations

Gilde Healthcare, the transatlantic specialist investment firm, is pleased to announce the addition of Jan Willem Bakker to its team as Partner & Head of Investor Relations. Jan Willem will focus on Gilde Healthcare’s investor...
September 2, 2024